178 related articles for article (PubMed ID: 23433478)
1. Use of ß-blockers and mortality following ovarian cancer diagnosis: a population-based cohort study.
Johannesdottir SA; Schmidt M; Phillips G; Glaser R; Yang EV; Blumenfeld M; Lemeshow S
BMC Cancer; 2013 Feb; 13():85. PubMed ID: 23433478
[TBL] [Abstract][Full Text] [Related]
2. Beta-blocker use and mortality following ovarian cancer diagnosis: a population-based study.
Couttenier A; Lacroix O; Silversmit G; Vaes E; De Schutter H; Robert A
Cancer Epidemiol; 2019 Oct; 62():101579. PubMed ID: 31450179
[TBL] [Abstract][Full Text] [Related]
3. Beta-blocker use and survival after pancreatic cancer surgery: A nationwide population-based cohort study.
Kirkegård J; Cronin-Fenton D; Lund A; Mortensen FV
Pharmacoepidemiol Drug Saf; 2024 Jan; 33(1):e5726. PubMed ID: 37946571
[TBL] [Abstract][Full Text] [Related]
4. β-Blockers and survival among Danish patients with malignant melanoma: a population-based cohort study.
Lemeshow S; Sørensen HT; Phillips G; Yang EV; Antonsen S; Riis AH; Lesinski GB; Jackson R; Glaser R
Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2273-9. PubMed ID: 21933972
[TBL] [Abstract][Full Text] [Related]
5. Impact of beta blockers on survival outcomes in ovarian cancer: a nationwide population-based cohort study.
Baek MH; Kim DY; Kim SO; Kim YJ; Park YH
J Gynecol Oncol; 2018 Nov; 29(6):e82. PubMed ID: 30207092
[TBL] [Abstract][Full Text] [Related]
6. Use of β-blockers, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and risk of breast cancer recurrence: a Danish nationwide prospective cohort study.
Sørensen GV; Ganz PA; Cole SW; Pedersen LA; Sørensen HT; Cronin-Fenton DP; Garne JP; Christiansen PM; Lash TL; Ahern TP
J Clin Oncol; 2013 Jun; 31(18):2265-72. PubMed ID: 23650417
[TBL] [Abstract][Full Text] [Related]
7. Statin use and mortality among ovarian cancer patients: A population-based cohort study.
Verdoodt F; Kjaer Hansen M; Kjaer SK; Pottegård A; Friis S; Dehlendorff C
Int J Cancer; 2017 Jul; 141(2):279-286. PubMed ID: 28411390
[TBL] [Abstract][Full Text] [Related]
8. Beta-Blockers for Exams Identify Students at High Risk of Psychiatric Morbidity.
Butt JH; Dalsgaard S; Torp-Pedersen C; Køber L; Gislason GH; Kruuse C; Fosbøl EL
J Child Adolesc Psychopharmacol; 2017 Apr; 27(3):266-273. PubMed ID: 27782771
[TBL] [Abstract][Full Text] [Related]
9. Preadmission use of antidepressants and risk of complications and death after colorectal cancer surgery: a nationwide population-based cohort study.
Lycke KD; Christiansen CF; Lund JL; Iversen LH; Nørgaard M
Colorectal Dis; 2019 Jun; 21(6):651-662. PubMed ID: 30740875
[TBL] [Abstract][Full Text] [Related]
10. Impact of preadmission treatment with calcium channel blockers or beta blockers on short-term mortality after stroke: a nationwide cohort study.
Sundbøll J; Schmidt M; Horváth-Puhó E; Christiansen CF; Pedersen L; Bøtker HE; Sørensen HT
BMC Neurol; 2015 Mar; 15():24. PubMed ID: 25884780
[TBL] [Abstract][Full Text] [Related]
11. Impact of Preadmission Opioid Treatment on 1-Year Mortality Following Nonsurgical Intensive Care.
Munch T; Christiansen CF; Pedersen L; Sørensen HT
Crit Care Med; 2018 Jun; 46(6):860-868. PubMed ID: 29528945
[TBL] [Abstract][Full Text] [Related]
12. Clinical impact of selective and nonselective beta-blockers on survival in patients with ovarian cancer.
Watkins JL; Thaker PH; Nick AM; Ramondetta LM; Kumar S; Urbauer DL; Matsuo K; Squires KC; Coleman RL; Lutgendorf SK; Ramirez PT; Sood AK
Cancer; 2015 Oct; 121(19):3444-51. PubMed ID: 26301456
[TBL] [Abstract][Full Text] [Related]
13. History of hypertension, heart disease, and diabetes and ovarian cancer patient survival: evidence from the ovarian cancer association consortium.
Minlikeeva AN; Freudenheim JL; Cannioto RA; Szender JB; Eng KH; Modugno F; Ness RB; LaMonte MJ; Friel G; Segal BH; Odunsi K; Mayor P; Zsiros E; Schmalfeldt B; Klapdor R; Dӧrk T; Hillemanns P; Kelemen LE; Kӧbel M; Steed H; de Fazio A; ; Jordan SJ; Nagle CM; Risch HA; Rossing MA; Doherty JA; Goodman MT; Edwards R; Matsuo K; Mizuno M; Karlan BY; Kjær SK; Høgdall E; Jensen A; Schildkraut JM; Terry KL; Cramer DW; Bandera EV; Paddock LE; Kiemeney LA; Massuger LF; Kupryjanczyk J; Berchuck A; Chang-Claude J; Diergaarde B; Webb PM; Moysich KB;
Cancer Causes Control; 2017 May; 28(5):469-486. PubMed ID: 28293802
[TBL] [Abstract][Full Text] [Related]
14. Multivariable analysis of association of beta-blocker use and survival in advanced ovarian cancer.
Gonzalez R; Gockley AA; Melamed A; Sugrue R; Clark RM; Del Carmen MG; Growdon W; Berkowitz RS; Horowitz NS; Worley MJ
Gynecol Oncol; 2020 Jun; 157(3):700-705. PubMed ID: 32222327
[TBL] [Abstract][Full Text] [Related]
15. Impact of beta blockers on epithelial ovarian cancer survival.
Diaz ES; Karlan BY; Li AJ
Gynecol Oncol; 2012 Nov; 127(2):375-8. PubMed ID: 22819786
[TBL] [Abstract][Full Text] [Related]
16. Preadmission Opioid Use and 1-Year Mortality Following Incident Myocardial Infarction: A Danish Population-Based Cohort Study (1997-2016).
Korsgaard S; Munch T; Horváth-Puhó E; Adelborg K; Christiansen CF; Pedersen L; Schmidt M; Sørensen HT
J Am Heart Assoc; 2023 Mar; 12(6):e026251. PubMed ID: 36892067
[TBL] [Abstract][Full Text] [Related]
17. β-Blockers in Atrial Fibrillation Patients With or Without Heart Failure: Association With Mortality in a Nationwide Cohort Study.
Nielsen PB; Larsen TB; Gorst-Rasmussen A; Skjøth F; Lip GY
Circ Heart Fail; 2016 Feb; 9(2):e002597. PubMed ID: 26823497
[TBL] [Abstract][Full Text] [Related]
18. Non-aspirin NSAID use and ovarian cancer mortality.
Verdoodt F; Dehlendorff C; Friis S; Kjaer SK
Gynecol Oncol; 2018 Aug; 150(2):331-337. PubMed ID: 29960709
[TBL] [Abstract][Full Text] [Related]
19. Association of β-blocker therapy with risks of adverse cardiovascular events and deaths in patients with ischemic heart disease undergoing noncardiac surgery: a Danish nationwide cohort study.
Andersson C; Mérie C; Jørgensen M; Gislason GH; Torp-Pedersen C; Overgaard C; Køber L; Jensen PF; Hlatky MA
JAMA Intern Med; 2014 Mar; 174(3):336-44. PubMed ID: 24247428
[TBL] [Abstract][Full Text] [Related]
20. β-Blocker usage and colorectal cancer mortality: a nested case-control study in the UK Clinical Practice Research Datalink cohort.
Hicks BM; Murray LJ; Powe DG; Hughes CM; Cardwell CR
Ann Oncol; 2013 Dec; 24(12):3100-6. PubMed ID: 24050955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]